Agarose LM |
|
A-1300-100 |
ABTBeads |
100 g |
EUR 230.4 |
Biosera Labtech Laboratories manufactures the biosera lm-t1711/1 reagents distributed by Genprice. The Biosera Lm-T1711/1 reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Biosera Labtech. Other Biosera products are available in stock. Specificity: Biosera Category: Lm-T1711/1
LM-41 |
|
MedChemExpress |
Get quote |
Ask for price |
|
Description: LM-41 is a Flufenamic acid-derived TEAD inhibitor hat strongly reduce the expression of CTGF, Cyr61, Axl and NF2. LM-41 inhibits migration of human MDA-MB-231 breast cancer cells[1]. |
G244-LM |
|
MedChemExpress |
10 mg |
EUR 887.46 |
|
Description: G244-LM is a potent and specific inhibitor of tankyrase 1/2 that inhibits Wnt signaling[1]. |
LM-4108 |
|
MedChemExpress |
1mg |
EUR 44.37 |
|
Description: LM-4108 (N-(2-Phenylethyl)-indomethacin amide) is a selective and orally active COX-2 inhibitor with an IC50 of 0.06 μM for purified human COX-2. LM-4108 shows anti-inflammatory activity and may be effective in prevention of cancer. Half-lives for the disappearance of 10 μM LM-4108 in rat, human, and mouse liver microsomes were 11 min, 21 min, and 51 min, respectively[1]. |
Test Assays information
LM-1484 |
|
HY-101686 |
MedChemExpress |
10mg |
EUR 7249.2 |
|
Description: LM-1484 is an antagonist of CysLT1 receptor and displays a higher affinity for 3H-LTC4 sites. |
LM-41 |
|
HY-155309 |
MedChemExpress |
Get quote |
Ask for price |
|
Description: LM-41 is a Flufenamic acid-derived TEAD inhibitor hat strongly reduce the expression of CTGF, Cyr61, Axl and NF2. LM-41 inhibits migration of human MDA-MB-231 breast cancer cells[1]. |
G244-LM |
|
HY-117705 |
MedChemExpress |
10 mg |
EUR 887.46 |
|
Description: G244-LM is a potent and specific inhibitor of tankyrase 1/2 that inhibits Wnt signaling[1]. |
LM-4108 |
|
HY-123639 |
MedChemExpress |
1mg |
EUR 44.37 |
|
Description: LM-4108 (N-(2-Phenylethyl)-indomethacin amide) is a selective and orally active COX-2 inhibitor with an IC50 of 0.06 μM for purified human COX-2. LM-4108 shows anti-inflammatory activity and may be effective in prevention of cancer. Half-lives for the disappearance of 10 μM LM-4108 in rat, human, and mouse liver microsomes were 11 min, 21 min, and 51 min, respectively[1]. |
